BDNF and HIV-associated neurocognitive disorder: We provide an overview of how targeting BDNF-TrkB signaling in the pathophysiology of HAND may be relevant for future therapies, and how 7,8 Dihydroxyflavone may be a potential adjunct therapeutic agent to current antiviral therapy.